Sign in
Not yet taking people in United StatesNo phase

Adaptive Radiotherapy for Patients With GBM

Key facts

Who runs it
Abramson Cancer Center at Penn Medicine
Where
Philadelphia, United StatesSee the site
Trial code
Status
Not yet recruiting
People taking part
20 people, planned
Starts
Jan 2027
Expected to end
Sept 2030
Type of study
Interventional
Treatments tested
  • MRI-Guided Adaptive Radiation Therapy
Record updated
12 November 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 11 criteriaShow less

Who can take part

  • Histologically confirmed IDH-wildtype glioblastoma (WHO Grade 4)
  • Age ≥ 18 years
  • Karnofsky Performance Status ≥ 60
  • Planned 30 or 15 fractions of radiation therapy with or without concurrent systemic therapy
  • Ability to undergo MRI imaging with IV gadolinium contrast
  • Ability to provide written informed consent
  • Multifocal tumors permitted if clinician anticipates they will be encompassed in a single radiation plan

Who cannot take part

  • Prior intracranial radiotherapy
  • Multicentric disease
  • Leptomeningeal dissemination
  • Pregnancy

Where in United States

  • University of PennsylvaniaPhiladelphia, United StatesContact: Marlowe EstiokoNot yet recruiting

About the trial

What the trial wants to find out

This is a single institution single arm feasibility study of MRI-guided, personalized adaptive radiation therapy with reduced margins for patients with glioblastoma.

The group in the trial

  • MRI-Guided Adaptive Radiation TherapyTreatment being tested

    The study intervention is MRI-guided adaptive radiation therapy with reduced treatment margins among patients with glioblastoma.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
ART-GBM: Feasibility Study of Adaptive Radiotherapy (ART) for Patients With Glioblastoma (GBM)
Record updated
12 November 2026